# The CHORAL Flow Study

> **NCT04073134** · PHASE4 · TERMINATED · sponsor: **Imperial College London** · enrollment: 12 (actual)

## Conditions studied

- Coronary Artery Disease
- Atherosclerosis
- Hyperlipidemias

## Interventions

- **BIOLOGICAL:** Evolocumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04073134
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-11
- **Primary completion:** 2022-03-27
- **Final completion:** 2022-05-27
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Funding withdrawn
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04073134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04073134, "The CHORAL Flow Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04073134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*